T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice
- PMID: 2426306
- PMCID: PMC423557
- DOI: 10.1172/JCI112587
T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice
Abstract
BALB/c mice immunized with Pseudomonas aeruginosa immunotype 1 polysaccharide develop protective T cell immunity to bacterial challenge. In vitro, T cells from immunized mice kill P. aeruginosa by production of a bactericidal lymphokine. The present study demonstrates that adoptive transfer of T cells from immunized BALB/c mice to granulocytopenic mice resulted in 97% survival on challenge with P. aeruginosa, compared with 17% survival with adoptive transfer of T cells from nonimmune BALB/c mice. This protection is specifically elicited by reexposure to the original immunizing antigen; adoptive recipients cannot withstand challenge with immunotype 3 P. aeruginosa. However, the adoptive recipients do survive simultaneous infection with both P. aeruginosa immunotypes 1 and 3. Adoptive transfer of T cells from the congenic CB.20 mice, which are unable to kill P. aeruginosa in vitro, provides only 20% protection to granulocytopenic mice. These studies indicate that transfer of specific immune T lymphocytes can significantly enhance the resistance to P. aeruginosa infection in granulocytopenic mice.
Similar articles
-
The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.J Immunol. 1991 Jan 1;146(1):316-20. J Immunol. 1991. PMID: 1898604
-
In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice.J Immunol. 1987 Apr 1;138(7):2272-7. J Immunol. 1987. PMID: 2951437
-
T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa.J Immunol. 1988 Apr 15;140(8):2746-52. J Immunol. 1988. PMID: 3128607
-
Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response.J Immunol. 1988 Mar 15;140(6):2039-45. J Immunol. 1988. PMID: 3126239
-
Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.Behring Inst Mitt. 1997 Feb;(98):269-73. Behring Inst Mitt. 1997. PMID: 9382750 Review.
Cited by
-
Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.Infect Immun. 1994 Jan;62(1):194-202. doi: 10.1128/iai.62.1.194-202.1994. Infect Immun. 1994. PMID: 8262627 Free PMC article.
-
CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.PLoS One. 2018 Oct 8;13(10):e0205521. doi: 10.1371/journal.pone.0205521. eCollection 2018. PLoS One. 2018. PMID: 30296305 Free PMC article.
-
Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.Clin Exp Immunol. 2002 Feb;127(2):206-13. doi: 10.1046/j.1365-2249.2002.01731.x. Clin Exp Immunol. 2002. PMID: 11876741 Free PMC article.
-
Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.Infect Immun. 1988 Nov;56(11):2925-32. doi: 10.1128/iai.56.11.2925-2932.1988. Infect Immun. 1988. PMID: 3139565 Free PMC article.
-
A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.Immunology. 1994 Nov;83(3):362-9. Immunology. 1994. PMID: 7835960 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources